6,511
Views
115
CrossRef citations to date
0
Altmetric
Reviews

Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring?

Pages 50-62 | Received 12 Aug 2015, Accepted 26 Oct 2015, Published online: 12 Jan 2016

References

  • Overgaard J. Editorial. The heat is (still) on – the past and future of hyperthermic radiation oncology. Radiother Oncol 2013;109:185–7
  • Januszewski A, Stebbing J. Letter. Hyperthermia in cancer: is it coming of age? Lancet Oncol 2014;15:565–6
  • Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond HM, Odijk H, et al. Temperature-controlled induction of BRCA2 degradation and homologous recombination deficiency sensitizes cancer cells to PARP-1 inhibition. Proc Natl Acad Sci 2011;108:9851–6
  • Kampinga HH. Cell biological effects on hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int J Hyperthermia 2006;22:191–6
  • Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biological rationale for thermal therapy. Int J Hyperthermia 2005;21:779–90
  • Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010;11:561–70
  • Issels RD, Lindner LH, Ghadjar P, Reichardt P, Hohenberger P, Verweij J, et al. Improved overall survival by adding regional hyperthermia to neoadjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): long-term outcomes of the EORTC 62961/ESHO randomized phase III study. Late breaking abstract. European Cancer Congress, Vienna, Austria, 25–29 September 2015
  • Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT) 1991;14:133–41
  • Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1996;34:1097–104
  • Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2005;61:145–53
  • Bicher HI, Wolfstein RS, Lewinsky BS, Frey HS, Fingerhut AG. Microwave hyperthermia as an adjunct to radiation therapy: summary experience of 256 multifraction treatment cases. Int J Radiat Oncol Biol Phys 1986;12:1667–71
  • Van der Zee J, Peer-Valstar JN, Rietveld PJM, de Graaf-Strukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 1998;40:1205–12
  • Sneed PK, Dewhirst MW, Samulski T, Blivin J, Prosnitz LR. Should interstitial thermometry be used for deep hyperthermia? Int J Radiat Oncol Biol Phys 1998;40:1015–17
  • Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079–85
  • Franckena M, Fatehi D, de Bruijne M, Canters RAM, van Norden Y, Mens JW, et al. Hyperthermia dose–effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009;45:1969–78
  • Fotopoulou C, Cho CH, Kraetschell R, Gellermann J, Wust P, Lichtenegger W, et al. Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarium cancer relapse: results of a pilot study. Int J Hyperthermia 2010;26:118–26
  • Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast [Comments]. Int J Radiat Oncol Biol Phys 1995;33:887–99
  • Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993;25:289–97
  • Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 1997;39:371–80
  • Issels RD, Prenninger SW, Nagele A, Boehm E, Sauer H, Jauch KW, et al. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. J Clin Oncol 1990;8:1818–29
  • Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, et al. Preoperative radio-chemotherapy in locally advanced recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000;48:381–91
  • De Bruijne M, van der Holt B, van Rhoon GC, van der Zee J. Evaluation of CEM43T90 thermal dose in superficial hyperthermia. A retrospective analysis. Strahlenther Onkol 2010;186:436–43
  • Field SB, Raaphorst GP. Thermal dose. In: Field SB, Hand JW, editors. An Introduction to the Practical Aspects of Clinical Hyperthermia. London: Taylor & Francis; 1990. pp 69–76
  • Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994;10:457–83
  • Pearce JA. Comparative analysis of mathematical models of cell death and thermal damage process. Int J Hyperthermia 2013;29:262–80
  • Field SB, Bleehen NM. Hyperthermia in the treatment of cancer. Cancer Treat Rev 1979;6:63–94
  • Field SB, Morris CC. The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol 1983;1:179–86
  • Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977;123:463–74
  • Sapareto SA, Hopwood LE, Dewey WC. Combined effects of X irradiation and hyperthermia on CHO cells for various temperatures and orders of application. Radiat Res 1978;73:221–33
  • Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003;19:252–66
  • Roti Roti JL. Cellular responses to hyperthermia (40–46 °C): cell killing and molecular events. Int J Hyperthermia 2008;24:3–15
  • Field SB. Hyperthermia in the treatment of cancer. Phys Med Biol 1987;32:789–811
  • Westra A. De invloed van straling op het vermogen tot proliferatie van in vitro gekweekte zoogdiercellen (The inpact of radiation on the proliferation potential of in vitro grown mammalian cells). PhD thesis, University of Amsterdam, 1971
  • Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol 2007;19:418–26
  • Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 2001;77:399–408
  • Oei AL, Vriend LEM, Crezee J, Franken NAP, Krawczyk PM. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol 2015;10:165–78
  • Konings AWT. Interaction of heat and radiation in vitro and in vivo. In: Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Principles and Practice of Thermoradiotherapy and Thermochemotherapy. Berlin: Springer Verlag; 1995. pp 89–102
  • Eppink B, Krawczyk PM, Stap J, Kanaar R. Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies. Int J Hyperthermia 2012;28:509–17
  • Vujaskovic Z, Song CW. Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia 2004;20:163–74
  • Reinhold HS, van den Berg AP. Effects of hyperthermia on blood flow and metabolism. In: Field SB, Hand JW, editors. An Introduction to the Practical Aspects of Clinical Hyperthermia. London: Taylor & Francis; 1990. pp 77–106
  • Lokshina AM, Song CW, Rhee JG, Levitt SH. Effect of fractionated heating on the blood flow in normal tissues. Int J Hyperthermia 1985;1:117–29
  • Song CW, Patten MS, Chelstrom LM, Rhee JG, Levitt SH. Effect of multiple heatings on the blood flow in RIF-1 tumours, skin and muscle of C3H mice. Int J Hyperthermia 1987;3:535–45
  • Song CW, Choi IB, Nah BS, Sahu SK, Osborn JL. Microvasculature and perfusion in normal tissue and tumors. In: Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Principles and Practice of Thermoradiotherapy and Thermochemotherapy. Berlin: Springer Verlag; 1995. pp 139–56
  • Song CW, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005;21:761–67
  • Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006;22:197–203
  • Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111–37
  • Van den Berg-Blok AE, Reinhold HS. Time–temperature relationship for hyperthermia induced stoppage of the microcirculation in tumors. Int J Radiat Oncol Biol Phys 1984;10:737–40
  • Vaupel P, Kallinowski F. Physiological effects of hyperthermia. Recent results in cancer research 1987;104:71–109
  • Iwata K, Shakil A, Hur WJ, Makepeace CM, Griffin RJ, Song CW. Tumor pO2 can be increased markedly by mild hyperthermia. Br J Cancer 1996;74:S217–221
  • Horsman MR, Overgaard J. Can mild hyperthermia improve tumor oxygenation? Int J Hyperthermia 1997;13:141–7
  • Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Dodge RK, Charles HC, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 1996;56:5347–50
  • Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, et al. Thermochemotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 2004;10:4287–93
  • Vaupel P, Kelleher DK. Pathophysiological and vascular characteristic of tumours and their importance for hyperthermia: heterogeneity is the key issue. Int J Hyperthermia 2010;26:211–23
  • Song CW, Park H, Griffin RJ. Review: improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001;155:515–28
  • Shakil A, Osborn JL, Song CW. Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Int J Radiat Oncol Biol Phys 1999;43:859–65
  • Vujaskovic Z, Poulson JM, Gaskin AA, Thrall DE, Page RL, Charles HC, et al. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys 2000;46:179–85
  • Griffin RJ, Dings RPM, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: role of tumor vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010;26:265–3
  • Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, Batinic-Haberle I, et al. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. PNAS 2010;107:20477–82
  • Secomb TW, Hsu R, Ong ET, Gross JF, Dewhirst MW. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncologica 1995;34:313–16
  • Myerson RJ, Singh AK, Bigott HM, Cha B, Engelbach JA, Kim J, et al. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning. Int J Hyperthermia 2006;22:93–115
  • Dewhirst MW, Sim DA, Gross J, Kundrat MA. Effect of heating rate and normal tissue microcirculatory function. In: Overgaard J, ed. Hyperthermic Oncology, Vol1. London: Taylor & Francis; 1984. pp 177–80
  • Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267–94
  • Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti BL, et al Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia 2011;26:1–26
  • Van Rhoon GC, Samaras T, Yarmolenko PS, Dewhirst MW, Neufeld E, Kuster N. CEM43 °C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol 2013;23:2215–27
  • Vaupel P. Pathophysiological mechanisms of hyperthermia in cancer therapy. In: Gautherie M, editor. Biological Basis of Oncologic Thermotherapy. Berlin: Springer; 1991. pp 73–134
  • Nah BS, Choi IB, Oh WY, Osborn JL, Song CW. Vascular thermal adaptation in tumors and normal tissue is rats. Int J Radiat Oncol Biol Phys 1996;35:95–101
  • Song CW. Effect of local hyperthermia in blood flow and microenvironment: a review. Cancer Res 1984;44:S4721–30
  • Rappaport DS, Song CW. Blood flow and intravascular volume of mammary adenocarcinoma 13762A and normal tissues of rat during and following hyperthermia. Int J Radiat Oncol Biol Phys 1983;9:539–47
  • Song CW, Rhee JG, Levitt SH. Blood flow in normal tissues and tumors during hyperthermia. J Natl Cancer Inst 1980;64:119–24
  • van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004 – clinical group consensus. Int J Hyperthermia 2008;24:111–22
  • Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia 2010;26:21–5
  • Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study. Int J Hyperthermia 2011;27:180–6
  • Zhao C, Chen J, Yu B, Chen X. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy. Int J Radiat Biol 2014;90:853–8
  • Datta NR, Gómez Ordóñez S, Gaipl US, Paulides MM, Crezee H, Gellermann J, et al. Local hyperthermia combined with radiotherapy and/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 2015;41:742–53
  • Cihoric N, Tsikkinis A, van Rhoon GC, Crezee J, Aebersold DM, Bodis S, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia early online 2015;31:609–14
  • Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989;16:551–8
  • Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the RTOG. Am J Clin Oncol 1991;14:133–41
  • Van der Zee J, Van der Holt B, Rietveld PJM, Helle PA, Wijnmaalen AJ, Van Putten WLJ, et al. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 1999;79:483–90
  • Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, et al. In regard to Vasanthan et al. Int J Radiat Oncol Biol Phys 2005;63:644
  • Van der Zee J, Van Rhoon GC, Wust P. In regard to Dr Vasanthan et al. Int J Radiat Oncol Biol Phys 2005;62:940–1
  • Lee HK, Antell AG, Perez CA, Straube WL, Ramachandran G, Myerson RJ, et al. Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: prognostic factors in 196 tumors. Int J Radiat Oncol Biol Phys 1998;40:365–75
  • Leopold KA, Dewhirst MW, Samulski TV, Dodge RK, George SL, Blivin JL, et al. Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 1993;25:841–7
  • Dinges S, Harder C, Wurm R, Buchali A, Blohmer J, Gellermann J, et al. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Strahlenther Onkol 1998;174:517–21
  • Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma: a multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996;12:3–20
  • Wust P, Stahl H, Dieckmann K, Scheller S, Loeffel J, Riess HJahnke V, et al. Local hyperthermia of N2/N3 cervical lymph node metastases: Correlation of technical and thermal parameters with response. Int J Radiat Oncol Biol Phys 1996;34:635–46
  • Perez CA, Patterson JH, Emami B. Evaluation of 45 °C hyperthermia and irradiation. Studies in a murine rhabdomyosarcoma model. Am J Clin Oncol 1993;16:469–76
  • Tilly W, Wust P, Rau B, Harder C, Gellermann J, Schlag P, et al. Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations. Int J Hyperthermia 2001;17:172–88
  • Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, et al. A phase II trial testing the thermal dose parameter CEM43°T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. Int J Hyperthermia 2001;17:283–90
  • Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiation therapy. Clin Cancer Res 2005;11:5206–14
  • Lagendijk JJW, van Rhoon GC, Hornsleth SN, Wust P, de Leeuw ACC, Schneider CJ J, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998;14:125–33
  • Dewhirst MW, Phillips TL, Samulski TV, Stauffer P, Shrivastava P, Paliwal B, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990;18:1249–59
  • Bruggmoser G, Bauchowitz S, Canters R, Crezee J, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011;187:605–9
  • Bruggmoser G, Bauchowitz S, Canters R, Crezee J, Ehmann M, Gellermann J, et al. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol 2012;188(Suppl2):198–211
  • Wust P, Gellermann J, Harder C, Tilly W, Rau B, Dinges S, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998;41:1129–37
  • Van Der Gaag ML, De Bruijne M, Samaras T, Van Der Zee J, Van Rhoon GC. Development of a guideline for the water bolus temperature in superficial hyperthermia. Int J Hyperthermia 2006;22:637–56
  • Arunachalam K, Maccarini PF, Stauffer PR. A thermal monitoring sheet with low influence from adjacent waterbolus for tissue surface thermometry during clinical hyperthermia. IEEE Tran Biomed Eng 2008;55:2397–406
  • Birkelund Y, Jacobsen S, Arunachalam K, Maccarini P, Stauffer PR. Flow patterns and heat convection in a rectangular water bolus for use in superficial hyperthermia. Phys Med Biol 2009;54:3937–53
  • Arunachalam K, Maccarini PF, Craciunescu OI, Schlorff JL, Stauffer PR. Thermal characteristics of thermobrachytherapy surface applicators for treating chest wall recurrence. Phys Med Biol 2010;55:1949–69
  • Fatehi D, van der Zee J, Notenboom A, van Rhoon GC. Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 2007;183:479–86
  • Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, et al. First results of triple modality treatment by combining radiotherapy, chemotherapy and hyperthermia for treatment of stage IIB-III-IVA cervical cancer. Cancer 2005;104:763–70
  • Fatehi D, van der Zee J, van der Wal E, van Wieringen WN, van Rhoon GC. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed. Int J Hyperthermia 2006;22:353–63
  • Breedveld S. Towards automated treatment planning in radiotherapy. Doctoral thesis, Erasmus University, Rotterdam, the Netherlands, 2013
  • Laginha KM, Verwoert S, Charrois GJR, Allen TM. Determination of doxorubicin levels in whole tumor and tumor nuclei in murice breast cancer tumors. Clin Cancer Res 2005;11:6944–9
  • Kok HP, Crezee J, Franken NAP, Stalpers LJA, Barendsen GW, Bel A. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distribution. Int J Rad Oncol Biol Phys 2014;88:739–45
  • Crezee J, van Leeuwen CM, Oei AL, Stalpers LJA, Bel A, Franken NA, et al. Thermoradiotherapy planning: integration in routine clinical practice. Int J Hyperthermia 2015 Dec 15, 1–9 early online
  • Verhaart RF, Verduijn GM, Fortunati V, Rijnen Z, van Walsum T, Veenland JF, et al. Accurate 3D temperature dosimetry during hyperthermia therapy by combining invasive measurements and patient specific simulations. Int J Hyperthermia 2015;31:686–92
  • Gellermann J, Hildebrandt B, Issels R, Ganter H, Wlodarczyk W, Budach V, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia correlation with response and direct thermometry. Cancer 2006;107:1373–82
  • Craciunescu OI, Stauffer PR, Soher BJ, Wyatt CR, Arabe O, Maccarini P, et al. Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. Med Phys 2009;36;4848–58

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.